burger

A pharmaceutical company
specialising in biological
medicinal products

3 fields of therapy
  • Immunology
  • Haemostasis
  • Intensive Care

Group executive commitee

Committee’s composition
3

Bioproduction sites in France

2/3

of LFB’s products treat rare diseases

15 medicines

prescribed to

hospital

€ 400 M in turnover

in 2018

22

medical specialties that regularly use
LFB’s medicines

1 st in France

in the field
of plasma-derived
medicinal products

Meeting with

GHU Paris Psychiatrie & Neurosciences ,

" In the context of the Covid-19 pandemic, In the context of the Covid-19 pandemic, LFB supports GHU Paris. "

LFB announces FDA approval of SEVENFACT®, a recombinant coagulation Factor VIIa

All news

2:54

LFB's commitment to patients and to IRIS association.

2:56

LFB Arras plant under construction, in September 2019 in video

2:11

LFB Group corporate film 2019

Living with peripheral neuropathies, a video supported by LFB

All videos

LFB announces FDA approval of SEVENFACT®, a recombinant coagulation Factor VIIa

GLOBAL PLASMA LEADERS COLLABORATE TO ACCELERATE DEVELOPMENT OF POTENTIAL COVID-19 HYPERIMMUNE THERAPY

LFB SIGNS AGREEMENT WITH XENOTHERA TO MANUFACTURE FIRST CLINICAL BATCH OF XENOTHERA'S XAV-19 FOR THE TREATMENT OF CORONAVIRUS INFECTIONS INCLUDING COVID-19

COVID-19: LFB and its employees are mobilized to provide medicines for patients.

LFB's commitment to patients

Discover the LFB Arras plant under construction - September 2019
15 medicines

prescribed to

hospital
3

Bioproduction sites in France
2/3

of LFB’s products treat rare diseases
1st in France

in the field
of plasma-derived
medicinal products

2:54

LFB's commitment to patients and to IRIS association.

there is 6 months

2:56

LFB Arras plant under construction, in September 2019 in video

there is 6 months

Living with peripheral neuropathies, a video supported by LFB

there is 2 years

2:11

LFB Group corporate film 2019

there is 4 years

Group executive commitee

Committee’s composition